Hydroxychloroquine reduces the risk of covid-19 in patients with rheumatic diseases: myth or reality?

Ann Rheum Dis. 2021 Jan;80(1):e6. doi: 10.1136/annrheumdis-2020-217556. Epub 2020 Apr 21.
No abstract available

Keywords: autoimmune diseases; hydroxychloroquine; outcome assessment, health care.

Publication types

  • Letter
  • Comment

MeSH terms

  • COVID-19*
  • Humans
  • Hydroxychloroquine / therapeutic use
  • Rheumatic Diseases* / drug therapy
  • Risk Factors
  • SARS-CoV-2

Substances

  • Hydroxychloroquine